Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Abou

Showing results (431-440 of 435) with videos related to

Pageof 44
Sort By:
You have reached the last page of results.This site can display upto 435 results.
Vaccine|July 31, 1998
Monk seal mortality: virus or toxin?A Osterhaus, M van de Bildt, L Vedder, et al.
Neurology|July 6, 2000
Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study GroupT A Glauser, M Nigro, R Sachdeo, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 26, 2015
Safety of a thickened extensive casein hydrolysate formulaYvan Vandenplas, Elisabeth De Greef, I Xinias, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Pageof 44

Showing results (431-440 of 435) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 435 results.
Vaccine|July 31, 1998
Monk seal mortality: virus or toxin?A Osterhaus, M van de Bildt, L Vedder, et al.
Neurology|July 6, 2000
Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study GroupT A Glauser, M Nigro, R Sachdeo, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|December 26, 2015
Safety of a thickened extensive casein hydrolysate formulaYvan Vandenplas, Elisabeth De Greef, I Xinias, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Neurology|April 28, 2004
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy SocietyJ A French, A M Kanner, J Bautista, et al.
Pageof 44